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Abstract: Aim: The effects of Guanabenz, an agonist of 2-adrenergic receptors routinely used in human medicine as an 
antihypertensive drug, were studied on NaIO3-induced retinal pigment epithelium (RPE) degeneration, laser-induced 
choroidal neovascularization (CNV) and choroidal blood flow, in animal models. 
Methods: The 35mg/kg NaIO3-induced RPE degeneration rat eyes were instilled with 1% Guanabenz eye drops 3 times a 
day for 7 days before NaIO3 injection, and then 2 to 4 weeks thereafter. RPE function was measured with c-wave of 
electroretinogram (ERG). Male Brown Norway rats were anesthetized to receive Nd:YAG laser to break the Bruch’s 
membrane. One percent Guanabenz eye drops were given likewise. The development of CNV was determined by 
fluorescein angiography performed on week 2 and week 4 using sodium fluorescein (FA) or fluorescein isothiocyanate-
dextran (FD70-FA). Colored microsphere technique was used for in vivo experiments to determine the choroidal blood 
flow in ocular hypertensive (40 mmHg) rabbit eyes. 
Results: The RPE function was protected significantly by Guanabenz according to the c-wave of ERG. Four weeks after 
NaIO3 injection, the amplitude of ERG c-wave was 0.422±0.092 millivolts in the control group, 0.103±0.04 millivolts in 
the NaIO3 group, and 0.254±0.061 millivolts in the Guanabenz+NaIO3 group. There was a significant protection of the 
ERG c-wave by Guanabenz as compared to NaIO3 group (P<0.01). The angiograms of FD70-FA showed decreased lesion 
size in the Guanabenz group. Four weeks after laser treatment, the size of the CNV lesion was 2.99±0.18 mm
2 in the 
control group, and 1.24±0.16 mm
2 in the Guanabenz group (P<0.01). The choroidal blood flow was significantly 
increased at 30 and 60 minutes after Guanabenz instillation as compared to corresponding controls. 
Conclusions: Guanabenz significantly protected RPE from NaIO3-induced degeneration, inhibited the development of 
CNV in laser-induced rat AMD model and increased choroidal blood flow markedly in vivo. 
Keywords: Guanabenz, sodium iodate, retinal pigment epithelium, age-related macular degeneration, choroidal blood flow. 
INTRODUCTION 
  Age-related macular degeneration (AMD) was first 
described in the medical literature in 1875 as “symmetrical 
central choroidoretinal disease occurring in senile persons” 
[1].
 It’s the main cause of legal blindness among those over 
65 years of age in the United States [2]. AMD was reported 
to account for 54% of all current cases of blindness among 
the Caucasian population in the United States [3]. The study 
predicted that as a result of the rising prevalence of AMD, 
the number of blind people in the US could increase by as 
much as 70% by 2020. 
  The RPE forms a monolayer between the neurosensory 
retina and the choroid. Its main functions are to supply 
nutrients to the adjacent photoreceptors and to dispose of 
shed photoreceptor outer segments by phagocytosis [4]. The 
RPE disabled to remove the metabolic waste results in the 
accumulation of drusen. RPE dysfunction causes the 
breakdown of the Bruch’s membrane. The breaks in Bruch’s 
membrane under the detached RPE serve as an entrance for  
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new and immature choroidal vessels into the subretinal space 
that lead to the formation of choroidal neovascularization. 
Furthermore, RPE loss may cause loss of choriocapillaris 
[5]. Therefore, RPE is a target for therapeutic approaches 
aimed at enhancement of photoreceptor survival in such 
ocular disease. 
  Guanabenz is a phenylacetyl-guanidine derivative, 
widely used as a centrally acting alpha2-adrenoceptor 
agonist, with an antihypertensive action similar to that of 
clonidine. It also has been reported to have protective effects 
against oxidative cytotoxicity in astrocytes [6, 7]. This study 
is to observe the effects of Guanabenz on NaIO3-induced 
retinal pigment epithelium (RPE) degeneration, laser-
induced choroidal neovascularization (CNV), and choroidal 
blood flow in animal models. 
METHODS 
Materials 
 Guanabenz  (purity98%), NaIO3 (purity99.5%), and 
dimethyl sulfoxide (DMSO, purity99.9%) were purchased 
from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). 
  Eight-week-old male Brown-Norway (BN) rats were 
purchased through LARR (Texas A&M University, USA). 
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and were housed in a standard animal room maintained at 
240.5with relative humidity of 145%, and with a 
12:12 h cyclic lighting schedule. All procedures were 
conformed to the ARVO Resolution on the use of animals in 
ophthalmic and vision research. Rats were anesthetized for 
all procedures with intramuscular injection of ketamine 
(35mg/kg) and xylazine (5mg/kg). The pupils were dilated 
with 1% atropine and 2.5% phenylephrine. 
  New Zealand white rabbits, weighing 2.5-3.0 kg, were 
purchased through LARR (Texas A&M University, USA). 
They were anesthetized with 35 mg/kg ketamine and 5 
mg/kg xylazine i.m, and half of the initial dose was given 
each 1 hour thereafter. 
NaIO3-Induced AMD Rat Model 
  Thirty BN rats were randomly divided into 3 groups, 10 
rats in normal group, 10 rats in NaIO3 group and 10 rats in 
Guanabenz+ NaIO3 group. Control group was instilled with 
solvent (Sigma-Aldrich) alone without NaIO3 injection. 
NaIO3 group was instilled with solvent plus 35mg/kg NaIO3 
injection through hypoglossal vein, whereas Guanabenz+ 
NaIO3 group was instilled with 1% Guanabenz eye drops 
plus 35mg/kg NaIO3 injection [8, 9]. Both eyes of all rats 
were instilled with 1 drop of solvent or 1% Guanabenz for 3 
times a day for 1 week before and 2 and 4 weeks after NaIO3 
injection [10]. At the end of 2 and 4 weeks, c-wave of ERG 
was recorded. 
  BN rats were dark adapted for 2 hours, pupils were 
dilated and then anesthetized. Before recording, one drop of 
0.5% tetracaine was given for surface anesthesia. All rats 
were kept warm during ERG measurement. DC-ERG 
recording methods developed by Peachey were followed 
[11]. Briefly, a 1-mm diameter glass capillary tube with 
filament (Sutter Instruments, Novato, CA) that was filled 
with Hanks balanced salt solution (Invitrogen, Carlsbad, CA) 
was used to connect with a Ag/AgCl wire electrode with a 
attached connector. The tubes were positioned to the corneal 
surface. Responses were amplified (dc-100 Hz; gain=1000X; 
DP-31, Warner Instruments, Hamden, CT) and digitized at 
10 Hz or 1000Hz. Data were analyzed by iWORX LabScribe 
Data Recording Software (iWorx0CB Sciences, Dover, NH). 
Light stimuli was derived from an optical channel using a 
fiber-lite high intensity illuminator (Dolan-Jenner Industries, 
Inc., MA), with neutral density filters (Oriel, Stratford, CT) 
placed in the light path to adjust stimulus luminance. The 
stimulus luminance used in this experiment was 3.22 log 
cd/m
2 and stimulated for 30 seconds. Luminance calibration 
was made by a Minolta (Ramsey, NJ) LS-110 photometer 
focused on the output side of the fiber optic bundle where 
the rat eye was located. 
Laser-Induced CNV Rat Model 
  Twenty rats were divided into 2 groups, 10 rats in normal 
group and 10 in Guanabenz group. The fundus was 
visualized with a VOLK super Pupil XL Biomicroscopy 
Lens ( Keeler Instrument Inc., Broomall, PA, USA). A 
double-frequency Nd:YAG laser (Laserex LP3532; Lumenis 
Inc., Salt Lake City, UT) was used at 532-nm wavelength. 
Laser parameters used were 100-m spot size, 0.15-second 
exposure and 150-200mw powers. Five laser spots were 
made to the ocular fundus at approximately equal distances 
around the optic nerves. Acute vapor bubbles suggested 
rupture of Bruch’s membrane [12]. Only laser spots with 
bubble formation were included in the study. Lesions with 
subretinal hemorrhage were excluded. 
  FA was performed 2 and 4 weeks after laser treatment 
with a digital fundus camera (TRC-50EX; TOPCON, Tokyo, 
Japan). Ten percent fluorescein isothiocyanate-dextran 
solution was injected through hypoglossal vein at 1.4mg/kg. 
Angiograms were taken continuously until 20 min after i.v. 
injection. The lesion size was evaluated with Imagenet2000 
digital imaging system (Topcon Medical Systems, Inc., 
Paramus, NJ, USA). 
Measurement of Choroid Blood Flow in Ocular 
Hypertensive Rabbit Eyes 
  An ocular hypertensive model was created by raising the 
intraocular pressure of the left eye to 40 mmHg, which 
reduced the ocular blood flow to approximately one third of 
the normal valued [13]. The left ventricle was cannulated 
through the right carotid artery for the injection of colored 
microspheres and the femoral artery was cannulated for 
blood sampling. One percent drug solution (50 μL) or 
vehicle (50 μL) was instilled topically to the left eye, and the 
ocular blood flow of the ocular hypertensive rabbits was 
measured with colored microspheres at 0, 30, 60 and 120 
minutes thereafter. At each time point, 2 million 
microspheres in 0.2 mL were injected as a reference, and 
blood samples were taken from the femoral artery for exactly 
1 minute following injection of the microspheres. The blood 
sample was collected in a heparinized tube and the volume 
was recorded. The rabbits were euthanized with an injection 
of 100 mg/kg pentobarbital sodium after the last blood 
sampling. The left eyes were enucleated and dissected into 
the retina, choroid, iris and ciliary body. The tissue samples 
were weighed. 
  The details of sample processing and microsphere 
counting were provided by E-Z Trac (Los Angeles, CA). In 
brief, a hemolysis reagent was added to the microfuge tubes 
with the blood sample, then vortexed and centrifuged for 30 
minutes at 6000 rpm. The supernatant was removed, and 
tissue/blood digest reagentsand  were added. The tubes 
were capped, vortexed, and centrifuged for 30 minutes again. 
The supernatant was removed, and the counting reagent was 
added, then vortexed, and centrifuged for 15 minutes at the 
same resolutions as above. The supernatant was removed, 
and the microspheres were resuspended in a precise volume 
of the counting reagent, The number of microspheres was 
counted with a hemocytometer. 
  Tissue/blood digest reagentwas added to the microfuge 
tubes with the tissue samples, sealed, and heated at 95 for 
15 minutes. The tubes were vortexed for 30seconds, then 
reheated and revortexed until all tissue samples were 
dissolved. The tissue/blood digest reagentwas added while 
the tissue samples were still hot, then the tubes were capped, 
vortexed, and centrifuged for 30 minutes. The protocol 
thereafter was the same as that used to process the blood 
sampled, and the microspheres were counted. 
  The blood flow of each tissue at a certain time point was 
calculated from the following equation: 
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in which Qm is the blood flow of a tissue in terms of 
μL/minute per mg, Cm is the microsphere count per mg of 
tissue, Qr is the flow rate of blood sample in terms of μL per 
minute, and Cr is the total microsphere count in the 
referenced blood sample. 
Statistical Analysis 
  All data were presented as meanSEM. One-way 
analysis of variance (ANOVA) and nonpaired Student’s t-
test was performed to analyze the significance between 
groups at a certain time point. The differences were 
considered significant at P<0.05. 
RESULTS 
Effect of Guanabenz on NaIO3-Induced RPE 
Degeneration 
 NaIO3-induced RPE degeneration was considered as dry 
AMD rat model and ERG c-wave was used to evaluate the 
function of RPE. Four weeks after NaIO3 injection, the 
amplitude of ERG c-wave was 0.422±0.092 millivolts in the 
control group, 0.103±0.04 millivolts in the NaIO3 group, and 
0.254±0.061 millivolts in the Guanabenz+NaIO3 group. 
ANOVA was used for statistical analysis. The least 
significant difference (LSD) post hoc test was used to 
examine whether there was any difference between groups 
with equal variance. There was a significant protection of the 
ERG c-wave by Guanabenz as compared to NaIO3 group 
(P<0.01). 
Effect of Guanabenz on Laser-induced Rat AMD Model 
  Angiography was widely used to measure the CNV area 
in laser-induced AMD rat model. The angiograms of FD70-
FA showed diminished lesion size in the Guanabenz group. 
Four weeks after laser treatment, the size of the CNV lesion 
was 2.99±0.18 mm
2 in the control group, and 1.24±0.16 mm
2 
in the Guanabenz group (P<0.01). 
Fig. (1). Effect of Guanabenz on NaIO3-induced RPE degeneration 
in rat eyes. Significant differences are indicated by ** (P<0.01). 
Effect of Guanabenz on Choroid Blood Flow of Ocular 
Hypertensive Rabbits 
  The choroid blood flow declined gradually in the vehicle 
control group. Guanabenz significantly increased the choroid 
blood flow at 30 and 60 min after drug instillation compared 
with the corresponding vehicle control group (P<0.05). 
 
 
Fig. (2). Effect of 1%Guanabenz on Laser-induced CNV Rat 
model. Significant differences are indicated by ** (P<0.01). 
 
Fig. (3). Angiogram of Laser-induced CNV Rat model, pic of 
Control group. 
 
Fig. (4). Angiogram of Laser-induced CNV Rat model, pic of 1% 
Guanabenz group. 
DISCUSSION 
  AMD is a debilitating disease of the eye, which manifests 
clinically with loss of central vision and pathologically with 
the accumulation of drusen, RPE degeneration, 
photoreceptor atrophy, and in wet AMD cases, with CNV 
formation. There are several risk factors, including age, race,  
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Fig. (5). Effect of guanabenz on ocular blood flow of ocular 
hypertensive rabbits. Data were expressed as means ± SEM. n=6 in 
each group; * was P < 0.05 and ** was P<0.01 as compared with 
the vehicle control group. 
smoking, and diet [14]. The etiology and pathogenesis of the 
disease include, but are not limited to oxidative stress, 
subclinical inflammation, complements formation, cytokine 
release, choroid atrophy, and the like. 
  The direct toxic effect of NaIO3 on RPE cells with 
secondary effects on photoreceptors and the choriocapillaries 
in vivo is well known [15]. The mechanisms of the toxicity 
of NaIO3 to RPE cells are as follows: first, NaIO3 can 
increase the ability of melanin to convert glycine into 
glyoxylate, a potential cell toxic compound [16]; second, 
NaIO3 could denaturant retinal proteins by changes of –SH 
levels in retina [17]; third, NaIO3 could cause considerable 
structure changes by breakdown of RPE diffusion barrier or 
by reduction of adhesion between RPE and photoreceptor 
cells [18-21]; finally, NaIO3 inhibits various enzyme 
activities, such as triose phosphate dehydragenase, 
succinodehydrogenase and lactate dehydrogenase [20, 22]. 
  The results of ERG c-wave measurement showed that 
Guanabenz significantly protected RPE cells from NaIO3-
induced injury. Slowing down of the RPE cells degeneration 
indicates prevention or slowing down of the AMD process. 
Imidazoline drugs, including guanabenz, were reported to 
show protective effects against naphthazarin-induced 
oxidative cytotoxicity, as evidenced by LDH release and 
Hoechst 33342/propidium iodide staining [6, 7]. The 
imidazoline drugs stabilized lysosomes and inhibited 
naphthazarin-induced lysosomal destabilization, as 
evidenced by acridine orange relocation. Guanabenz 
inhibited, the leakage of lysosomal cathepsin D to cytosol, 
the decreased mitochondrial potential, and the release of 
mitochondrial cytochrome c, which were induced by 
naphthazarin. The lysosomal destabilization by oxidative 
stress and other apoptotic signals and subsequent cathepsin 
D leakage to the cytosol can induce apoptotic changes of 
mitochondria and eventually cell death. Therefore, lysosomal 
stabilization by imidazoline drugs may be ascribed to their 
protective effects against oxidative cytotoxicity. However, 
how Guanabenz exactly expresses its protective effect on 
RPE remains unclear. Further study is needed to reveal the 
mechanism of Guanabenz in RPE protection. 
  In general, degeneration of RPE cells is the first step of 
dry-AMD, and the CNV formation is the key point of dry-
AMD transformation to wet-AMD. FA diagraphs showed 
that Guanabenz significantly decreased the intensity of 
fluorescein leakage from the photocoagulated lesions and the 
size of CNV induced by laser treatment on Brown Norway 
rats. Thus, Guanabenz showed its protection ability in 
converting dry-AMD to wet-AMD. 
  The results of choroid blood flow showed a significant 
increase in choroid blood flow by Guanabenz. The 
pathological studies have highlighted the role of oxidative 
stress and inflammatory changes in the pathogenesis of 
AMD [23]. The increase of choroid blood flow may facilitate 
removal of metabolic wastes, inflammatory factors and 
replenish nutrients to RPE and photoreceptors. 
Consequently, it may change the microenviroment, the 
balance between pro- and antiangiogenesis factors, and the 
change of the process of angiogenesis [24]. 
  Guanabenz has been used for many years to treat 
hypertension on a daily basis, without major side-effects. 
The results suggest that it could be used to prevent and treat 
AMD in the future. 
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